Association of CXCR7 and CXCR4 expression with tumor immune phenotypes in tubo-ovarian high-grade serous carcinoma
Irish Journal of Medical Science (1971 -) · 2026-10 · 195 (5) · 2567-2574
DOI: 10.1007/s11845-026-04437-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Irish Journal of Medical Science (1971 -), online erschienen am 13.05.2026. Verfasst von Burak Tatar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Ondokuz Mayis University, Samsun, Türkiye. Hauptthemen laut MEDLINE: Receptors, CXCR, Receptors, CXCR4, Ovarian Neoplasms, Cystadenocarcinoma, Serous. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ondokuz Mayıs University.
Abstract (Originalsprache)
Background
Tumor-infiltrating lymphocytes (TILs) are associated with favorable outcomes in high-grade serous ovarian carcinoma (HGSC); however, the tumor microenvironment may modulate immune cell infiltration. This study aimed to evaluate the association between tumor and stromal expression of CXCL12, tumor expression of CXCR4 and CXCR7, immune phenotypes, and survival outcomes in tubo-ovarian HGSC.
Methods
Eighty-six patients with primary tubo-ovarian HGSC who underwent cytoreductive surgery were retrospectively analyzed. Immunohistochemical expression of CXCL12 (tumor and stroma), CXCR4, and CXCR7 was assessed. TILs were semi-quantitatively scored and dichotomized as low (score 1) or high (scores 2–3). Immune phenotypes were classified as immunogenic, immune-excluded, or immune-ignorant. Recurrence-free survival (RFS) and overall survival (OS) were analyzed using Kaplan–Meier methods, log-rank tests, and Cox regression. Multivariable logistic regression was used to identify factors associated with high TILs.
Results
Median RFS was 23.2 months (95% CI, 19.2–27.1) and median OS was 47.3 months (95% CI, 36.3–55.0). RFS differed significantly across immune phenotypes (log-rank p=0.047), with shorter RFS observed in the immune-excluded phenotype compared with the immunogenic phenotype (hazard ratio, 2.20; 95% CI, 1.14–4.25). High tumor CXCR7 expression was independently associated with a lower likelihood of high TILs (adjusted odds ratio, 0.22; 95% CI, 0.07–0.65). CXCL12 expression was not associated with survival outcomes.
Conclusion
Tumor CXCR7 expression is associated with reduced lymphocytic infiltration and an immune-excluded phenotype in HGSC, suggesting a potential role of the CXCR7 axis in shaping the tumor immune microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Medicine, Ondokuz Mayis University, Samsun, Türkiye.
- Department of Pathology, Ondokuz Mayis University, Samsun, Türkiye.
- Department of Medical Biology, Faculty of Medicine, Ondokuz Mayis University, Samsun, Türkiye.
- Department of Molecular Medicine, Ondokuz Mayis University, Samsun, Türkiye. sgunes@omu.edu.tr.
- Department of Medical Biology, Faculty of Medicine, Ondokuz Mayis University, Samsun, Türkiye. sgunes@omu.edu.tr.
- Stem Cell Application and Research Center, Samsun, Türkiye. sgunes@omu.edu.tr.
Förderung
- Ondokuz Mayıs University
Zitieren
APA
Tatar, B., Caliskan, S., Uygun, F. N., Ergün, S., Hekim, N., Kefeli, M., & Gunes, S. (2026). Association of CXCR7 and CXCR4 expression with tumor immune phenotypes in tubo-ovarian high-grade serous carcinoma. Irish Journal of Medical Science (1971 -), 195(5), 2567-2574. https://doi.org/10.1007/s11845-026-04437-5
Vancouver
Tatar B, Caliskan S, Uygun FN, Ergün S, Hekim N, Kefeli M, et al. Association of CXCR7 and CXCR4 expression with tumor immune phenotypes in tubo-ovarian high-grade serous carcinoma. Irish Journal of Medical Science (1971 -). 2026;195(5):2567-2574. doi:10.1007/s11845-026-04437-5
BibTeX
@article{Tatar2026,
author = {Tatar, Burak and Caliskan, Sultan and Uygun, Fatma Nur and Ergün, Sercan and Hekim, Neslihan and Kefeli, Mehmet and Gunes, Sezgin},
title = {Association of CXCR7 and CXCR4 expression with tumor immune phenotypes in tubo-ovarian high-grade serous carcinoma},
journal = {Irish Journal of Medical Science (1971 -)},
year = {2026},
volume = {195},
number = {5},
pages = {2567--2574},
doi = {10.1007/s11845-026-04437-5}
}
EUVIMED